MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
10.88
-0.95 (-8.03%)
Feb 21, 2025, 4:00 PM EST - Market closed
MBX Biosciences Employees
MBX Biosciences had 27 employees as of December 31, 2023.
Employees
27
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,043,667
Market Cap
363.58M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 27 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
MBX News
- 4 days ago - MBX Biosciences to Participate in March Investor Conferences - GlobeNewsWire
- 6 weeks ago - MBX Biosciences Announces Positive Phase 1 Topline Results for MBX 1416 for the Treatment of Post-bariatric Hypoglycemia - GlobeNewsWire
- 3 months ago - MBX Biosciences Announces Last Subject Last Visit in Phase 1 Trial of MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia - GlobeNewsWire
- 4 months ago - MBX Biosciences to Participate in Upcoming November Investor Conferences - GlobeNewsWire
- 5 months ago - MBX Biosciences Presents MBX 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual Meeting - GlobeNewsWire
- 5 months ago - MBX Biosciences Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 5 months ago - U.S. IPO Weekly Recap: 3 Biotechs Lead Active September IPO Market - Seeking Alpha
- 5 months ago - MBX Biosciences shares surge 44% in blockbuster Nasdaq debut - Reuters